Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01272102 · ClinicalTrials.gov registry record
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
A clinical trial of Glaucoma, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 119
- Enrollment target
- 4
- Study locations
NCT01272102: Completed study of Glaucoma, sponsored by Carl Zeiss Meditec.
NCT01272102 is a study of Glaucoma that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 119 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (87% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01272102, a study of Glaucoma, has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
- 4
- Study locations
Study Summary
To determine the area under the Receiver Operator Characteristic Curve (AUC) for the Ganglion Cell Analysis (GCA) average thickness.
Conditions Studied
Study Locations (4)
California
- Stanford Eye Institute - Palo Alto
Florida
- Bascom Palmer Eye Institute - Miami
Texas
- Glaucoma Associates of Texas - Dallas
Utah
- Utah Eye Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-03 |
What the finished NCT01272102 record still lists
NCT01272102 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT01272102 reports a single indexed study location in California, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT01272102 about?
NCT01272102 is a clinical study titled "Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma". To determine the area under the Receiver Operator Characteristic Curve (AUC) for the Ganglion Cell Analysis (GCA) average thickness.
What is the current status of trial NCT01272102?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2010-11. Estimated completion is 2011-03.
What conditions does trial NCT01272102 study?
This clinical trial studies the following conditions: Glaucoma.
Who is sponsoring clinical trial NCT01272102?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01272102 being conducted?
This trial has 4 study locations across California, Florida, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01272102's enrollment target sits among peer trials
119 39th of 92 higher than 53 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia